Jeffrey Skinner
Keine laufenden Positionen mehr
Vermögen: 91 140 $ am 30.04.2024
Profil
Jeffrey Skinner worked as the Director of Business Development at SteriMax, Inc. from 2012 to 2014.
He then worked as the Vice President of Business Development at ChitogenX, Inc. After that, he worked as the Vice President of Business Development at Valeo Pharma, Inc. from 2014 to 2023.
Mr. Skinner received his undergraduate degree and MBA from the University of Western Ontario in 1997 and 1999, respectively.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VALEO PHARMA INC CLASS A
1,42% | 15.03.2023 | 1 402 150 ( 1,42% ) | 91 140 $ | 30.04.2024 |
Ehemalige bekannte Positionen von Jeffrey Skinner
| Unternehmen | Position | Ende |
|---|---|---|
| VALEO PHARMA INC. | Corporate Officer/Principal | 01.07.2023 |
SteriMax, Inc.
 SteriMax, Inc. Pharmaceuticals: MajorHealth Technology SteriMax, Inc. provides pharmaceutical products and services. The firm specializes in the development, production, marketing and distribution of essential hospital and retail pharmacy products to the Canadian healthcare market. Its products include BaciJect, Bupivacaine Injection BP, ceFAZolin for Injection, and AcetaZOLAMIDE for Injection USP. The company was founded by Mahen J. Acharya and is headquartered in Oakville, Canada. | Corporate Officer/Principal | 01.07.2014 |
| CHITOGENX INC. | Corporate Officer/Principal | - |
Ausbildung von Jeffrey Skinner
| University of Western Ontario | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CHITOGENX INC. | Health Technology |
| VALEO PHARMA INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
SteriMax, Inc.
SteriMax, Inc. Pharmaceuticals: MajorHealth Technology SteriMax, Inc. provides pharmaceutical products and services. The firm specializes in the development, production, marketing and distribution of essential hospital and retail pharmacy products to the Canadian healthcare market. Its products include BaciJect, Bupivacaine Injection BP, ceFAZolin for Injection, and AcetaZOLAMIDE for Injection USP. The company was founded by Mahen J. Acharya and is headquartered in Oakville, Canada. | Health Technology |
